These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 6979566

  • 1. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
    Giclas PC.
    J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
    [Abstract] [Full Text] [Related]

  • 2. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
    Ziccardi RJ.
    J Immunol; 1986 May 01; 136(9):3378-83. PubMed ID: 3485688
    [Abstract] [Full Text] [Related]

  • 3. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ, Ramsey J, Hammer CH, Frank MM.
    J Immunol; 1983 Jul 01; 131(1):403-8. PubMed ID: 6602833
    [Abstract] [Full Text] [Related]

  • 4. Antibody-independent activation of C1. II. Evidence for two classes of nonimmune activators of the classical pathway of complement.
    Peitsch MC, Kovacsovics TJ, Tschopp J, Isliker H.
    J Immunol; 1987 Mar 15; 138(6):1871-6. PubMed ID: 3029223
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
    Doekes G, van Es LA, Daha MR.
    Immunology; 1983 Jun 15; 49(2):215-22. PubMed ID: 6852866
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Generation of the classical pathway C3 convertase (EAC4b2a) by proteolytic enzymes.
    Loos M, Heinz HP.
    Acta Pathol Microbiol Immunol Scand Suppl; 1984 Jun 15; 284():67-74. PubMed ID: 6375257
    [Abstract] [Full Text] [Related]

  • 13. In vitro activation of complement by isolated human heart subcellular membranes.
    Giclas PC, Pinckard RN, Olson MS.
    J Immunol; 1979 Jan 15; 122(1):146-51. PubMed ID: 762412
    [Abstract] [Full Text] [Related]

  • 14. Antibody-independent C1 activation by E. coli.
    Tenner AJ, Ziccardi RJ, Cooper NR.
    J Immunol; 1984 Aug 15; 133(2):886-91. PubMed ID: 6376630
    [Abstract] [Full Text] [Related]

  • 15. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
    Gronski P, Bodenbender L, Kanzy EJ, Seiler FR.
    Behring Inst Mitt; 1984 Nov 15; (76):29-41. PubMed ID: 6335396
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of immune precipitation by complement.
    Hong K, Takata Y, Sayama K, Kozono H, Takeda J, Nakano Y, Kinoshita T, Inoue K.
    J Immunol; 1984 Sep 15; 133(3):1464-70. PubMed ID: 6747294
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.